Xipoint Pharmaceutical: Ferric Sodium Succinate Oral Solution Receives Drug Registration Certificate

MetaMuskRat · 2026-03-24T20:23:08+00:00

People's Finance News, March 23 - Xipoint Pharmaceuticals ((301130)3) announced on March 23 that it recently received a Drug Registration Certificate issued by the National Medical Products Administration (NMPA) for Ferric Protein Succinate Oral Solution. This medication is used to treat latent or overt iron deficiency anemia caused by insufficient iron intake or absorption disorders, acute or chronic blood loss, and infections, as well as absolute and relative iron deficiency anemia during pregnancy and lactation.

MetaMuskRat

2026-03-24 20:23:08

People’s Financial News, March 23 — Xidian Pharmaceutical (301130) announced on March 23 that it recently received the “Drug Registration Certificate” for Protein Ferrous Succinate Oral Solution issued by the National Medical Products Administration. Protein Ferrous Succinate Oral Solution is used to treat latent or overt iron deficiency anemia caused by insufficient iron intake or absorption disorders, acute or chronic blood loss, and infections, as well as anemia during pregnancy and lactation, including both absolute and relative iron deficiency anemia.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.